Summary
Vitamin B6 nutritional status is assessed by measuring the plasma concentration of one of its vitamers, pyridoxal-phosphate (PLP). Several conditions, e.g., myocardial infarction (MI), can disturb the dynamic equilibrium between the different vitamers resulting in transiently low plasma PLP levels. An important question is whether these low plasma PLP levels observed during MI represent a transient state of deficiency and what the possible clinical consequences of such a fall in plasma PLP could be. Since the main metabolic function of PLP is to act as an intracellular coenzyme, it was decided to monitor the changes not only of PLP but also of PL (transport form of vitamin B6) in both the plasma and red blood cells (RBCs) in patients with myocardial infarctions (MI): 16 patients with proven MI were investigated measuring the aforementioned parameters at regular intervals. It was found that the approximately 40% fall in plasma PLP levels was accompanied by an equivalent increase in RBC PLP levels. Subsequently plasma PLP concentrations returned to normal but RBC PLP values were maintained at the newly elevated steady state (without any vitamin supplementation). Since membranes are impermeable to PLP, the only way in which PLP could have been redistributed to the intracellular compartment was through hydrolysis to PL and rephosphorylation once inside the RBCs. This compartmentalization could be an important adaptive response since it has been shown that PLP reduces O2 affinity of deoxygenated hemoglobin, thereby facilitating O2 delivery to the tissues. In addition it would also enhance the proposed storage function of RBCs for PLP and PL which is said to be an important source for muscle vitamin B6 which again is essential for energy production by the muscle cells during ischemia.
Similar content being viewed by others
Abbreviations
- AST:
-
Aspartate Aminotransferase (EC 2.6.1.1)
- CK:
-
Creatine Kinase (EC 2.7.3.2)
- CV:
-
coefficient of variation
- HPLC:
-
high performance liquid chromatography
- LD:
-
lactate dehydrogenase (EC 1.1.1.27)
- MI:
-
myocardial infarction
- MRC:
-
Medical Research Council
- NAD+ :
-
oxidized nicotinamide adenine dinucleotide
- NADH:
-
reduced nicotinamide adenine dinucleotide
- PL:
-
pyridoxal
- PLP:
-
pyridoxal-5′-phosphate
- PLSC:
-
pyridoxal semicarbazone
- PLPSC:
-
pyridoxal-5′-phosphate semicarbazone
- PM:
-
pyridoxamine
- PMP(PNP)-oxidase:
-
pyridoxamine-phosphate- (pyridoxine-phosphate) — oxidase
- PN:
-
pyridoxine
- RBCs:
-
red blood cells
- SEM:
-
standard error of the mean
References
Anderson BB, Fulford Jones CE, Child JA, Beard MEJ, Bateman CJT (1971) Conversion of vitamin B6 compounds of active forms in the red blood cell. J Clin Invest 50:1901–1909
Barnard HC, Vermaak WJH, Potgieter GM (1986) The effect of acute prolonged starvation on the concentrations of vitamin B6 a aldehyde derivatives in whole bood. Int J Vit Nutr Res 56:351–354
Buss D, Hamm MW, Mehansho H, Henderson LM (1980) Transport and metabolism of pyridoxine in the perfused small intestine and the hind limb of rat. J Nutr 110:1055–1663
Chabner B, Livingston D (1970) A simple enzymic assay for pyridoxal phosphate. Anal Biochem 34:413–423
Digerness SB, Reddy WJ (1976) The malate-aspartate shuttle in heart mitochondria. J Mol Cell Cardiol 8:779–785
Felig P (1970) Alanine: Key role in gluconeogenesis. Science 167:1003–1004
Fonda ML, Harker CW (1982) Metabolism of pyridoxine and protein binding of the metabolites in human erythrocytes. Am J Clin Nutr 35:1391–1399
Labadarios D, Brink PA, Weich HFH, Visser L, Louw MEJ, Shepard GS, van Stuijvenberg ME (1987) Plasma vitamin A, E, C and B6 levels in myocardial infarction. S Afr Med J 71:561–563
Lui A, Lumeng L, Li T-K (1985) The measurement of plasma vitamin B6 compounds: comparison of a cation-exchange HPLC method with the open-column chromatographic method and the L-tyrosine apo-decarboxylase assay. Am J Clin Nutr 41:1236–1243
Lumeng L, Brashear RV, Li T-K (1974) Pyridoxal-5′-phosphate in plasma: source, protein-binding and cellular transport. J Lab Clin Med 84:334–343
Lumeng L, Ryan MV, Li T-K (1978) Validation of the diagnostic value of plasma pyridoxal-5′-phosphate measurements in vitamin B6 nutrition of the rat. J Nutr 108:545–553
Lumeng L, Lui A, Li T-K (1980) Plasma content of B6 vitamers and its relationship to hepatic vitamin B6 metabolism. J Clin Invest 66:688–695
Lumeng L, Schenker S, Li T-K, Brashear RE, Crompton MC (1984) Clearance and metabolism of plasma pyridoxal-5′-phosphate in the dog. J Lab Clin Med 103:59–68
Neely JR, Rovetto MJ, Oram JF (1972) Myocardial utilization of carbohydrates and lipids. Progr Cardiovasc Dis 15:289–329
Neely JR, Morgan HE (1974) Relationship between carbohydrate and lipid metabolism and the energy balance of heart muscle. Ann Rev Physiol 36:415–459
Neely JR, Whitmet JT, Rovetto MJ (1975) Effect of coronary blood flow on glycolytic flux and intracellular pH in isolated heart rats. Circ Res 37:733–741
Rhinehart JF, Greenberg LD (1949) Arteriosclerotic lesions in pyridoxine deficient monkeys. Am J Pathol 25:481–491
Sauberlich H (1968) In: Sebrell WH, Harris RS (eds) The vitamins, vol. 2. Academic Press, New York, p 44
Schnackerz KD, Benesch RE, Kwong S, Benesch R, Helmreich EJM (1983) Specific receptor sites for pyridoxal-5′-phosphate and pyridoxal 5′-deoxy methylene-phosphatase at the ∝ and β NH2-terminal region of hemoglobin. J Biol Chem 258:872–875
Serfontein WJ, Ubbink JB, De Villiers LS, Rapley CH, Becker PJ (1985) Plasma pyridoxal-5′-phosphate level as risk index for coronory artery disease. Atherosclerosis 55:357–361
Serfontein WJ, Ubbink JB, De Villiers LS, Becker PJ (1986) Depressed plasma pyridoxal-5′-phosphate levels in tobacco smoking men. Atherosclerosis 59:341–346
Sloger MS, Reynolds RC (1981) Pyridoxal-5′-phosphate in whole blood, plasma and blood cells of postpartum nonlactating and lactating rats and their pups. J Nutr 111:823–830
Temesvari P, Szilagyi T, Eck E, Boda D (1983) Effects of an antenatal load of pyridoxine (vitamin B6) on the blood oxygen affinity and prolactin levels in newborn infants and their mothers. Acta Pediatr Scand 72:525–529
Ubbink JB, Serfontein WJ, De Villiers LS (1985) The stability of pyridoxal-5-phosphate semicarbazone: applications in plasma vitamin B6 analysis and population surveys of vitamin B6 nutritional status. J Chromatogr 342:277–284
Vermaak WJH, Barnard HC, Van Dalen EMSP, Potgieter GM (1986) Correlation between pyridoxal-5′-phosphate levels and the percentage activation of aspartate aminotransferase enzyme in haemolysate and plasma during in vitro incubation studies with different B6 vitamers. Enzyme 35:215–224
Vermaak WJH, Barnard HC, Potgieter GM, Theron H du T (1987) Vitamin B6 and coronary artery disease: Epidemiological observations and case studies. Atherosclerosis 63:235–238
Whyte MP, Mahuren DJ, Vrabel LA, Coburn SP (1985) Markedly increased circulating pyridoxal-5′-phosphate levels in hypophosphatasia — alkaline phosphatase acts in vitamin B6 metabolism. J Clin Invest 76:752–756
Wilson RG, Davis RE (1983) Clinical chemistry of vitamin B6. Adv Clin Chem 23:1–68
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Vermaak, W.J.H., Barnard, H.C., Van Dalen, E.M.S.P. et al. Compartmentalization of pyridoxal-5′-phosphate during the acute phase of myocardial infarction. Klin Wochenschr 66, 428–433 (1988). https://doi.org/10.1007/BF01745511
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01745511